Common cancer biomarkers.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-3433PMID 16540643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adhesion, migration and communication in melanocytes and melanoma.

  2005cited by this paper
• Translational Crossroads for Biomarkers

  2005cited by this paper
• Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1

  2005cited by this paper
• RNA amplification for successful gene profiling analysis

  2005cited by this paper
• Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK.

  2005cited by this paper
• Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer.

  2005cited by this paper
• In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.

  2005cited by this paper
• Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.

  2005cited by this paper
• Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells

  2005cited by this paper
• Variance in the Expression of 5-Fluorouracil Pathway Genes in Colorectal Cancer

  2005cited by this paper
• Multiclass cancer classification and biomarker discovery using GA-based algorithms

  2005cited by this paper
• Significance of Matrix Metalloproteinase 9 and CD34 Expressions in Esophageal Carcinoma: Correlation With DNA Content

  2005cited by this paper
• Pitfalls in the use of rt-PCR as a prognostic indicator in melanoma.

  2005cited by this paper
• RT-PCR tyrosinase expression in the peripheral blood of melanoma patients

  2004cited by this paper
• Melanoma-restricted genes

  2004cited by this paper
• Protein Profiling of Microdissected Prostate Tissue Links Growth Differentiation Factor 15 to Prostate Carcinogenesis

  2004cited by this paper
• Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis

  2004cited by this paper
• Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker

  2004cited by this paper
• Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell Cancer

  2004cited by this paper
• Selection and validation of endogenous reference genes using a high throughput approach

  2004cited by this paper
• Metastasis markers in bladder cancer: a review of the literature and clinical considerations.

  2004cited by this paper
• Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.

  2004cited by this paper
• A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue

  2004cited by this paper
• Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives.

  2004cited by this paper
• Genomic and Proteomic Expression Patterns in HPV-16 E6 Gene Transfected Stable Human Carcinoma Cell Lines

  2004cited by this paper
• Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8‐expressing transgenic mice

  2004cited by this paper
• hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

  2003cited by this paper
• Genetic algorithms applied to multi-class prediction for the analysis of gene expression data

  2003cited by this paper
• Activation of ErbB3–PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas

  2003cited by this paper
• Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B

  2003cited by this paper
• Tumors as elusive targets of T-cell-based active immunotherapy.

  2003cited by this paper
• Limitations to the use of the CA-125 antigen level in ovarian cancer

  2003cited by this paper
• Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

  2003cited by this paper
• Basal cell carcinoma.

  2003cited by this paper
• Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

  2002cited by this paper
• Identification of Genes Associated with Dedifferentiation of Hepatocellular Carcinoma with Expression Profiling Analysis

  2002cited by this paper
• Advantages of mRNA amplification for microarray analysis.

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• New feature subset selection procedures for classification of expression profiles

  2002cited by this paper
• Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea

  2002cited by this paper
• Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

  2001cited by this paper
• t(10;11)‐Acute leukemias with MLL‐AF10 and MLL‐ABI1 chimeric transcripts: Specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines

  2001cited by this paper
• Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination

  2001cited by this paper
• Prostate-specific antigen.

  2001cited by this paper
• Multiclass cancer diagnosis using tumor gene expression signatures

  2001cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• Support vector machine classification and validation of cancer tissue samples using microarray expression data

  2000cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• Knowledge-based analysis of microarray gene expression data by using support vector machines.

  2000cited by this paper
• High-fidelity mRNA amplification for gene profiling

  2000cited by this paper
• Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display

  2000cited by this paper
• Prostate cancer: is the PSA test the answer?

  1998cited by this paper
• CEA: is it of value in colorectal cancer?

  1995cited by this paper
• CEA: is it of value in colorectal cancer?

  1995cited by this paper
• Measuring the accuracy of diagnostic systems.

  1988cited by this paper
• Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.

  1986cited by this paper

• Discriminating extracellular vesicles by their membranes

  2026cites this paper
• An appraisal at a glance of metallome and disease biomarkers.

  2025cites this paper
• Upgradation of Biosensor: An Emerging Paradigm for Advanced Biomedical Application

  2025cites this paper
• Nano optical (bio)sensing platforms for early detection of pediatric cancer

  2025cites this paper
• Framework Nucleic Acids: Innovative Tools for Cellular Sensing and Therapeutics

  2024cites this paper
• Biosensors for metastatic cancer cell detection.

  2024cites this paper
• Digital Magnetic Proximity Extension RPA-CRISPR/Cas12a-Assisted Immunoassay with Attomolar Sensitivity

  2024cites this paper
• Biosensors for cancer detection: A review

  2024cites this paper
• Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials

  2024cites this paper
• Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers

  2023cites this paper
• Role of CD147 in the development and diagnosis of hepatocellular carcinoma

  2023cites this paper
• Ultrasound-Induced Gold Nanoparticle United with Acoustic Reprogramming of Macrophages for Enhanced Cancer Therapy.

  2023cites this paper
• Amino-modified-silica-coated gadolinium-copper nanoclusters, conjugated to AS1411 aptamer and radiolabeled with technetium-99 m as a novel multimodal imaging agent.

  2022cites this paper
• Magnetic properties-based biosensors for early detection of cancer

  2022cites this paper
• Advancing Tumor Microenvironment Research by Combining Organs-on-Chips and Biosensors.

  2022cites this paper
• Examining binding capacity of aptamers based on fluorescence image segmentation

  2022cites this paper
• CLEC3B Identified as a Potential Lung Cancer Biomarker in Serum by Aptamer‐Capture Technology

  2021cites this paper
• The Interplay between Housing Environmental Attributes and Design Exposures and Psychoneuroimmunology Profile—An Exploratory Review and Analysis Paper in the Cancer Survivors’ Mental Health Morbidity Context

  2021cites this paper
• Potency analysis of cellular therapies: the role of molecular assays

  2021cites this paper
• Serum growth differentiation factor-15 analysis as a malnutrition marker in hemodialysis patients

  2021cites this paper
• Dietary effects of Clostridium autoethanogenum protein substituting fish meal on growth, intestinal histology and immunity of Pacific white shrimp (Litopenaeus vannamei) based on transcriptome analysis.

  2021cites this paper
• Biosensors: a better biomarker for diseases diagnosis

  2020cites this paper
• GDF15 knockdown suppresses cervical cancer cell migration in vitro through the TGF‐β/Smad2/3/Snail1 pathway

  2020cites this paper
• Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma

  2020cites this paper
• CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker

  2019cites this paper
• Non-invasive biodiversified sensors: A modernised screening technology for cancer.

  2019cites this paper
• Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents

  2019cites this paper
• Aptamers: novelty tools for cancer biology

  2018cites this paper
• Toxicogenomics applied to in vitro Cell Transformation Assay reveals mechanisms of early response to cadmium.

  2018cites this paper
• Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes

  2018cites this paper
• Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer

  2017cites this paper
• Biosensors and biomarkers: promising tools for cancer diagnosis

  2017cites this paper
• Metabolomic biomarkers of pancreatic cancer: a meta-analysis study

  2017cites this paper
• AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics

  2017cites this paper
• SPR platform based on image acquisition for HER2 antigen detection

  2017cites this paper
• Fabrication of graphene based aptasensors for early detection of prostate cancer by experimental and computational techniques

  2017cites this paper
• Developments in the Electrochemical Bionanosensors for the Predictive Diagnosis of Prostate and Breast Cancer

  2017cites this paper
• Screen-printed electrode produced by printed-circuit board technology. Application to Cancer Biomarker Detection by means of plastic antibody as sensing material.

  2016cites this paper
• The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process.

  2016cites this paper
• CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.

  2016cites this paper
• Fabrication And Biological Applications Of Graphene-Based Nanostructures

  2016cites this paper
• Mechanistic study of anti-tumor activity of sulforaphane on nasopharyngeal carcinoma

  2016cites this paper
• Microfluidic Plasmonic Biosensor for Breast Cancer Antigen Detection

  2016cites this paper
• Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma

  2016cites this paper
• The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis

  2015cites this paper
• Candidate genes in quantitative trait loci associated with absolute and relative kidney weight in rats with Inherited Stress Induced Arterial Hypertension

  2015cites this paper
• Aptamers and Their Significant Role in Cancer Therapy and Diagnosis

  2015cites this paper
• Potency Analysis of Cellular Therapies

  2015cites this paper
• Nanotechnology for Cancer Diagnostics and Therapy - An Update on Novel Molecular Players

  2014cites this paper
• Beta-2-microglobulin gene transfer in hla class i deficient tumor cells using recombinant adenovirus

  2014cites this paper
• Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis

  2014cites this paper
• Tissue Specific Transplantation Antigen P35B (= GDP-4-keto-6-D-Deoxymannose Epimerase-Reductase) (TSTA3)

  2014cites this paper
• Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.

  2013cites this paper
• Growth Differentiation Factor 15 in Multiple Myeloma: A Microenvironment Factor Predictive of Response to Treatment?

  2013cites this paper
• Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?

  2013cites this paper
• Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes

  2013influential citation
• Computational methods to analyze molecular determinants behind phenotypes

  2013cites this paper
• Ten cancer associated genes identified in peripheral blood mononuclear cells from patients with pancreatic adenocarcinoma.

  2013cites this paper
• Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies

  2012cites this paper
• A Minimal Connected Network of Transcription Factors Regulated in Human Tumors and Its Application to the Quest for Universal Cancer Biomarkers

  2012cites this paper
• Prospective nested case–control study of feature genes related to leukemic evolution of myelodysplastic syndrome

  2012cites this paper
• Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

  2012cites this paper
• The stable traits of melanoma genetics: an alternate approach to target discovery

  2012cites this paper
• Microenvironment and Immunology Bioactivity and Prognostic Signi fi cance of Growth Differentiation Factor GDF 15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma

  2012cites this paper
• 3.10 – Issues and Pitfalls in Biomarker Development and Clinical Relevance

  2012cites this paper
• Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network

  2011cites this paper
• Cutaneous melanoma in situ: translational evidence from a large population-based study.

  2011cites this paper
• Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis

  2011cites this paper
• Mammalian plasma membrane proteins as potential biomarkers and drug targets

  2011cites this paper
• Integrated nanohole array surface plasmon resonance sensing device using a dual-wavelength source

  2011cites this paper
• CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer

  2011cites this paper
• High-Throughput Screening in Medical Diagnosis and Prognosis

  2011cites this paper
• Signatures Associated with Acute Rejection: Allograft Rejection

  2011cites this paper
• Regulation of M3 Muscarinic Receptor Expression and Function by Transmembrane Protein 147

  2011cites this paper
• Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes

  2010cites this paper
• Global Transcriptional Analysis for Biomarker Discovery and Validation in Cancer and Hematological Malignancy Biologic Therapies

  2010cites this paper
• Biomarkers of Cancer

  2010cites this paper
• Translational Medicine: Application of Omics for Drug Target Discovery and Validation

  2010cites this paper
• Quality assessment of cellular therapies: the emerging role of molecular assays

  2010cites this paper
• Predictive and prognostic molecular markers for cancer medicine

  2010cites this paper
• Translational lab-on-a-chips with the development of a novel cancer screening method

  2010cites this paper
• Robust multi-tissue gene panel for cancer detection

  2010cites this paper
• Identification of a 17-protein signature in the serum of lung cancer patients.

  2010cites this paper
• MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

  2010cites this paper
• Biosensors: the new wave in cancer diagnosis.

  2010cites this paper
• HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection

  2009influential citation
• Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biology

  2009cites this paper
• Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

  2009cites this paper
• Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a

  2009cites this paper
• Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

  2009cites this paper
• Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen

  2009cites this paper
• Bottom up: a modular view of immunology.

  2008cites this paper
• ImmuneManipulation ofAdvancedBreast Cancer : An InterpretativeModel of the Relationship Between Immune System andTumor Cell Biology

  2008cites this paper
• Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.

  2008cites this paper
• Biomarker method validation in anticancer drug development

  2008cites this paper
• Microarray methods for protein biomarker detection.

  2008cites this paper
• A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers

  2008influential citation
• Integrative Genomic Data Mining for Discovery of Potential Blood-Borne Biomarkers for Early Diagnosis of Cancer

  2008cites this paper
• New Tumor Biomarkers

  2008cites this paper
• Potency analysis of cellular therapies: the emerging role of molecular assays

  2007cites this paper